{
  "report_rows": [
    {
      "kpi": "Adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$1.72 vs. cons $1.66",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Revenue",
      "prediction": "BEAT",
      "answer": "pred ~$23.2B vs. cons $22.88B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Organic sales growth (YoY)",
      "prediction": "BEAT",
      "answer": "pred ~+8% vs. cons ~+6%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 Adjusted EPS guidance",
      "prediction": "BETTER",
      "answer": "guide ~$6.80-7.00 (mid ~$6.90) vs. cons ~$6.85 (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 Adjusted sales guidance",
      "prediction": "BETTER",
      "answer": "guide ~$93-94B (mid ~$93.5B) vs. cons ~$93.2B (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 Free cash flow guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$8.25-8.75B (mid ~$8.5B) vs. cons ~$8.5B (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Backlog / book-to-bill (munitions framework color)",
      "prediction": "BETTER",
      "answer": "guide backlog ~$275B+ vs. prior $271B (Q2'26); framework deals ~$multi-B not yet in backlog",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": 1.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 0.4,
  "day5_path": "FADE",
  "day5_rationale": "Likely quality beat-and-raise, but with a beat-and-raise 'mostly assumed' and RTX at a premium multiple (richer than LMT/NOC), the bar is high. Initial pop should be muted (~+1%), and out-period math tempers follow-through: the guide raise largely re-affirms rather than materially lifts FY26 EPS/FCF, munitions framework deals remain out of numbers, and shorter-cycle aftermarket/GTF risks cap upside \u2014 so early gains partially fade over the week.",
  "day5_confidence": "LOW"
}